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Abstract 
Study of Ultrasound-Induced Leakage from DOPC/DPPC/Cholesterol Model Membranes 
Maureen W. Waweru 
Advisors: Steven P. Wrenn, Ph.D and Peter A. Lewin, Ph.D 
 
 Ultrasound-mediated controlled drug release is beneficial because it is a non invasive 
process that is effective in the treatment of diseases, and which minimizes toxic side effects that 
are common with other systemic treatments. As a model for the application of ultrasound in drug 
delivery, this paper outlines a quantitative study of the controlled release of calcein from small 
unilamellar vesicles (SUVs) (~100nm) after exposure to low frequency ultrasound (LFUS). The 
SUVs comprise of varying compositions of 1, 2-dioleoyl-phosphocholine (DOPC), 1, 2-
dipaltimoyl-phosphocholine (DPPC), and cholesterol.  
Together, these compounds provide a model lipid membrane system that can be used to 
study how lipid composition and membrane phase behavior affect ultrasound-induced release of 
molecules encapsulated within the core of lipid vesicles. In this study, small unilamellar vesicles 
encapsulating fluorescent dye, calcein, were prepared by Rapid Solvent Exchange (RSE) 
technique. These lipid vesicles were exposed to ultrasound at a frequency of 24 kHz using a 
probe sonicator, at 30 sec time intervals followed by 3 min resting time. The leakage of calcein 
from the vesicles was then quantified by steady state fluorescence spectroscopy. Calcein release 
profiles obtained indicated that varying the molar amounts of cholesterol had different effects on 
the lipid membrane's ability to resist leakage by ultrasound.   
Further studies were performed to investigate the effect that polyethylene glycol (PEG) 
has on ultrasound-mediated leakage of calcein from liposomes in the solid-ordered phase. 
Previous studies have shown that PEGylated liposomes are considered to be more susceptible to 
ultrasound. In this work, calcein leakage from liposomes that contained different molar quantities 
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of DPPC and 1, 2 Distearoyl-Sn-Glycero-3-Phosphoethanolamin-N-methoxy(poly(ethylene 
glycol))2000 (DSPE-PEG2000) was analyzed and the results showed an increase in ultrasound-
mediated leakage of calcein at 1% and 5% molar quantities of the polymer.  
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CHAPTER 1: INTRODUCTION 
 Ultrasound is used in medicine for both diagnostic and therapeutic applications and can 
be categorized as either low- or high-intensity. Currently, high intensity focused ultrasound is 
used in tumor ablation and kidney stone shattering[1]. The use of low frequency ultrasound 
(LFUS) to increase the permeability of biological membranes is currently being studied for 
transdermal delivery[2].  Another application of ultrasound which is the motivation behind the 
work discussed in this paper, is the use of LFUS for targeted and triggered delivery of drugs to a 
desired site. Currently, the challenge in drug delivery research is fast release of amphipathic, 
membrane residing drugs, and the slow release of hydrophobic water soluble drugs from drug 
carriers such as liposomes. The use of ultrasound for the triggered and controlled release of drugs 
to a particular site would be therapeutically effective as it will ensure that specified doses reach 
target sites thereby reducing chances of side effects.  
 The purpose of ultrasound in delivery of drugs is to increase the permeability of 
biological barriers such as cell walls. Previous studies have sought to determine if LFUS does 
increase the permeability of liposome based drug carriers. One such group is Schroeder et al. [3], 
whose research showed that irradiating sterically stabilized liposomes with ultrasound allowed 
for release of anticancer drugs cisplatin and doxorubicin and that the liposome membrane 
resealed once ultrasound exposure was stopped.  
The process by which impermeable membranes are made permeable once a sound field 
emitted by ultrasound is introduced, is known as sonoporation and is required for ultrasound-
based therapies [4, 5]. Though the mechanism by which sonoporation occurs is not fully 
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understood, the fact that drug release is observed once membranes are exposed to ultrasound, 
suggests there are interactions between ultrasound and the lipid membranes.  
 Previous research studies have sought to investigate various membrane properties and 
their effect on ultrasound. One such study is by Pong et al.[6]who investigated the effect of 
ultrasound frequency on dye release from lipid vesicles with different size and lamellarities. 
Their research shows that with LFUS, drug release does correlate with membrane curvature, with 
vesicles with larger curvatures being more resistant to leakage. Other studies have shown that the 
addition of PEG polymers to lipid membranes enhances their response to ultrasound. Lin and 
Thomas[7] showed that LFUS-induced release increased when a concentration of up to 5 mol% 
of DPPE-PEG2000 was used. Research by Small et al. [8] focused on the role of lipid membrane 
phase behavior on the kinetics of ultrasound-induced transport across lipid bilayers. Their work 
showed that different lipid membrane phases influence ultrasound leakage differently and that 
cholesterol has a significant role in membrane permeability.  
 The research work discussed in this paper seeks to verify previous works by studying the 
influence that membrane phase behavior has on ultrasound-induced membrane leakage. This will 
be achieved by using a DOPC/DPPC/Cholesterol lipid model membrane system because it has 
similar components to biological membranes and can be controlled by varying lipid and 
cholesterol compositions.  Additionally, this research will investigate the effect of adding 
surfactants to lipid membranes once they are exposed to ultrasound. This will be attained by 
analyzing the effect that DSPE-PEG2000 polymer has on ultrasound-induced leakage from lipid 
vesicles consisting of purely DPPC. The overall goal of this work is to use liposomes as a mimic 
of cell membranes and to get insight on sonoporation. Currently they are used in drug delivery 
and later it is hoped that their use in wound healing can be achieved.  
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 Chapter 2 describes the goals and objectives of this research. Chapter 3 will give a 
background review of the principles of ultrasound and lipid membrane properties. Chapter 4 will 
discuss the techniques used to prepare vesicles along with ultrasound parameters and 
fluorescence measurements used. In chapter 5 the results are presented and chapter 6 contains the 
discussion of these results. Finally, chapter 7 contains conclusions and suggestions for further 
studies. 
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CHAPTER 2: RESEARCH GOALS 
 The primary objective of this study is to investigate the influence that lipid phase 
behavior and membrane composition have on lipid membrane response to ultrasound. This goal 
was attained by performing experiments that focused on how different compositions of lipids and 
various concentrations of cholesterol and PEG polymer affected the quantity of calcein released 
from liposomes when exposed to ultrasound at specific parameters.  
 The specific aims of this research were as follows:  
Specific Aim 1: Study the influence of lipid phase behavior on ultrasound-induced leakage of 
calcein from liposomes with different DOPC/DPPC compositions and cholesterol amounts.  
Tasks:   
1. Prepare liposomes in pure DOPC, liquid-disordered phase (ld), liquid-liquid two phase region, 
liquid-ordered phase (lo) and in pure DPPC or solid-ordered phase (So).  
2.  Expose liposomes to ultrasound at 24 kHz frequency, for an ON time of 30s and OFF time of 
3 min for a total time of 22 min. Examine, the ultrasound-induced permeability of the various 
lipid compositions by using steady state fluorescence to quantify the amount of calcein released 
by each individual lipid composition.  
3. Study the effect of cholesterol concentrations on lipid membrane response to ultrasound and 
discern a relationship between phase behavior and ultrasound by analyzing the fluorescence 
spectroscopy data obtained  
Specific Aim 2:  Study the effect of DSPE-PEG2000 on ultrasound-induced release of calcein 
from liposomes in the solid-ordered state.  
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Tasks:  
1. Prepare liposomes consisting of pure DPPC and DPPC mixed with 1%, 5% and 8 mol % 
DSPE-PEG2000.   
2.  Expose liposomes to ultrasound at 24 kHz frequency, for an ON time of 30s and OFF time of 
3 min for a total time of 22 min. Examine, how ultrasound-induced permeability of the 
PEGylated liposomes compares after analysis of steady state fluorescence spectroscopy of 
calcein.   
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CHAPTER 3: BACKGROUND 
 This chapter presents the background and motivation behind the research study detailed 
in this report. Understanding the interaction between ultrasound and lipid model membranes 
requires knowledge of ultrasound physics as well as lipid membrane behavior. Below, the 
physics of ultrasound are presented followed by details pertaining to lipid membranes and their 
behavior.  
3.1 Ultrasound Acoustics 
 Many ultrasound-based therapies require sonoporation in order for drugs or other 
encapsulated molecules to be released from the vesicles. This process of sonoporation occurs 
through acoustic cavitation, the mechanism by which ultrasound temporarily increases or causes 
membrane permeability [9]. Specifically, acoustic cavitation is the formation and/or activity of 
gas- or vapor-filled cavities such as bubbles, in a medium exposed to an oscillating pressure[10, 
11]. The bubbles are suggest to result from pre-existing stable bubbles that were present in the 
liquid, or bubbles that were formed when the pressure dropped below the vapor pressure of the 
liquid. The oscillation of these bubbles after an ultrasound wave passes through is what is termed 
as cavitation[12]. It is believed that acoustic cavitation is the mechanism by which the leakage 
studies discussed in this paper occur.   
3.1.1 Stable Cavitation 
 There are two types of acoustic cavitation; transient cavitation and stable cavitation. In 
stable cavitation process, bubbles respond to an oscillating pressure that causes their continual 
oscillation [1]as they grow. According to Margulis[13], the vibrating surface of the bubble can 
generate fluid movement that is known as microstreaming and which leads to shear stress near 
7 
 
the bubble. Though the bubble does not collapse as a result of stable cavitation, it may lead to 
membrane permeabilization. 
3.1.2 Rectified Diffusion  
During acoustic cavitation, the bubbles are said to be exposed to two pressure cycles; 
rarefraction, which is negative pressure, and condensation, which is the positive pressure.  In 
rarefraction, pressure forces the bubble to expand through the diffusion of gas into the bubble. 
The increase in size of the bubble over time under an oscillating pressure field is facilitated by a 
process known as rectified diffusion.  In the next cycle of the acoustice wave, during the 
condensation cycle, the gas in the bubble diffuses out of the bubble as pressure increases due to 
contraction of the bubble and decrease in the bubble surface area[14].  
3.1.3 Transient Cavitation 
 Transient cavitation, which is also known as inertial cavitation occurs when bubbles 
oscillate with increasingly large amplitudes until the outward expansion exceeds the critical 
radius known as the bubble resonant radius, upon which the bubble grows abruptly and then 
collapses violently[14].  
 After the bubble collapses, this results in the production of short-lived intense local heating and 
high pressures [1]. Transient cavitation is considered responsible for the disruption of 
membranes when using ultrasound in the low frequency range [15, 16]. Schroeder et al. [3], have 
studied the ability of LFUS to control the release of drugs that have different physical and 
chemical properties from liposomes. This group suggests that LFUS may induce the formation of 
transient pore-like defects to the liposome membrane which allows for the release of drugs.  
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3.1.4 The RPNNP Equation  
 The Rayleigh-Plesset-Noltingk-Neppiras-Poritsky (RPNNP) equation describes bubble 
oscillation and shows that both stable and transient cavitation depend on frequency, exposure 
time, temperature and pressure [9] and it defines the dynamics of bubble collapse and oscillation.  
𝑅𝑹 + 3𝑹2
2
=  1
𝜌
 ��𝑝0 +  2𝜏𝑅0 −  𝑝𝑣 � � 𝑅0𝑅  �3 𝑘 +  𝑝𝑣 −  2𝜏𝑅 −  4𝜂𝑹𝑅 − 𝑝0 −  𝑃(𝑡)� (1) 
According to the equation, R0 is the initial radius of the bubble, 𝑘 is the polyprotic 
exponent of the gas, ρ is the density of the medium, Po is the static pressure in the fluid, τ is the 
surface tension, Ro is the radius of the bubble at equilibrium, Pv is the vapor pressure, P (t) is the 
pressure imposed on the fluid, and η is the shear viscosity of the surrounding fluid.  
3.2 Phospholipids and their properties 
Phospholipids are the major component of all cell membranes. They are of interest in 
research because of their ability to form lipid bilayers when they are dispersed in aqueous media. 
Phospholipids consist of a phosphate group, a diglyceride, and a single organic molecule such as 
choline. They are amphipathic in nature because they have hydrophilic heads which are attracted 
to water and hydrophobic tails which are repelled by water and forced to aggregate. The 
hydrophobic tails of phospholipids consist of two acyl chains that can be either saturated, 
unsaturated, or one of each. The head group is either a phosphate group or an alcohol attached to 
a phosphate group. In this study, phospholipids 1, 2-dioleoyl-phosphocholine (DOPC) with two 
unsaturated 18-carbon chains, and 1, 2-dipaltimoyl-phosphocholine (DPPC) with two saturated 
16-carbon chain were used to prepare lipid vesicles along with cholesterol. Their structures are 
shown on Figure 3.1.  
 In 1963, Bangham, discovered that in water phospholipids arrange themselves 
spontaneously into bilayer structures which he named liposomes. These lipid vesicles arrange 
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themselves in such a way that their hydrophobic tails are shielded from the water by the 
hydrophilic heads [17]. Today, liposomes are defined as spherical vesicles in which a single or 
several continuous lipid bilayer(s) separate the external aqueous medium from the intra-
liposomal aqueous core [1]. This unique structure of liposomes allows them to be considered as 
suitable carriers for many compounds, including drugs [18].  Molecules loaded into the liposome 
can be hydrophobic, hydrophilic and amphipathic in nature and their location in the liposome, 
either in the liposome membrane or intra-liposome aqueous core, will depend on their 
physiochemical characteristics [1].   
 One of the reasons why lipid bilayers display different phase behaviors is because of the 
presence of cholesterol within the bilayer. Cholesterol is a key component of biological 
membranes, and is considered to significantly modify membrane behavior by increasing the 
tensile strength of the membrane [19] and decreasing permeability [20]. It is therefore of interest 
to investigate how cholesterol affects the response of liposome model membranes to ultrasound.  
3.3 Liposome Composition and Lipid Phase Behavior  
 The complex amphiphilic structure of lipids is responsible for the interesting phase 
behavior they display, and has significant implications in cell membrane structure and function. 
Based mainly on lipid composition and the packing of their lipid hydrocarbon chains, lipid 
bilayers can be in the solid-ordered phase (So), the liquid-disordered (ld) phase, the liquid-liquid 
phase and the liquid-ordered phase (lo). The solid-ordered phase is also referred to as crystalline, 
solid or gel phase, while the liquid-disordered is also called the fluid, or liquid phase[21]. 
Addition of cholesterol into lipid membranes that have saturated or monosaturated lipids, causes 
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the membranes to pack more tightly or cohesively, stiffening and lengthening their lipid acyl 
chains and therefore reducing the area per molecule [22-24].  
 This effect of cholesterol on the lipid membrane, is known as the condensation effect and 
is considered to increase the rigidity of the membrane and its shear resistance and toughness [22-
24] and is what leads to the formation of membranes in the liquid-ordered phase. The liquid-
ordered phase is characterized by the lateral mobility of the liquid-disordered phase and the 
mechanical properties of the solid-ordered phase [8]. At low concentrations of cholesterol the 
membrane has high lateral mobility and the lipids can "flip-flop" from one leaflet to another. As 
the concentration of cholesterol is increased, pockets known as lipid rafts are formed within the 
membrane. These lipid rafts are basically, pockets of liquid-ordered formed in pockets of liquid 
disordered and cause the membrane to undergo line tension.  
3.4 Line Tension 
 As the lipid membrane transitions from the liquid-disordered phase to the liquid-ordered 
phase as the concentration of cholesterol is increased, lipid rafts consisting of domains of liquid-
disordered in a majority of liquid ordered will be formed. Subsequently, there will be height 
differences between the two phases because the lo phase is characterized by ordered hydrocarbon 
chains that are fully extended as compared to those in the ld phase. This misalignment causes line 
tension to occur at the edge of lo and ld domains. This is a result of the exposure of the 
hydrocarbon chains in lo to water and therefore the creation of unfavorable tension between 
hydrophobic and hydrophilic molecules [25]. Coalescing the domains to form the minimum 
number of domains, leads to a reduction in line tension. In natural membranes, line tension is 
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reduced because of the presence of many phospholipids of varying lengths and saturations which 
act as lineactants thereby relieving line tension[26].  
3.5 Fluorescent Measurements 
 As mentioned previously, understanding membrane behavior is important in gaining 
insight on the interaction between biological cell membranes and ultrasound and is therefore 
crucial in gene and drug delivery. To evaluate the effects of membrane permeation and mimic 
drug release from cells, the model membranes prepared in this study encapsulated a self-
quenching fluorophore whose leakage can be detected by fluorescence spectroscopy. In this 
study, calcein shown on Figure 3.2 was encapsulated in different lipid compositions and upon 
exposure to ultrasound, leakage from the model membranes occurred and fluorescence intensity 
was shown to increase.  
 As a result of its ability to self-quench at concentrations higher than 70mM due to 
collision transfer, when calcein is encapsulated within the liposome aqueous core, it is unable to 
fluoresce. When the liposomes are subjected to ultrasound, the calcein molecules are released 
and able to spread out and fluoresce. This change in fluorescence intensity was indicative of 
calcein leakage and membrane permeation upon exposure to ultrasound. Steady state 
spectroscopy measures the light that is emitted once a fluorophore returns to its ground state after 
being excited by a laser beam. The fraction of dye released is determined by the equation below:  
Fraction Release (%) = (𝐹𝑜𝑏𝑠 − 𝐹𝑖𝑛𝑡)(𝐹𝑇𝑋 − 𝐹𝑖𝑛𝑡) −  100%  (2) 
where Fobs is the fluorescence observed when the liposomes are exposed to ultrasound, Fint is the 
initial fluorescence before the application of ultrasound (0% leakage), and FTX is the intensity 
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after complete release. It has been determined that complete release is obtained when liposomes 
are exposed to Triton X-100. This is a surfactant shown to cause the dissolution of vesicles  
because it has a small hydrophobic tail that easily partitions in and out of lipid membranes 
causing destabilization of the membrane [7]. Specifically, at concentrations greater than 0.3%, 
Triton X-100 has been shown to cause catastrophic solubilization of the membrane [7].   
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Figure 3.1 Chemical structure of DPPC (A) which has two fully saturated 16-carbon chains, 
DOPC (B) which has two unsaturated 18-carbon chains. Cholesterol (C). 
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Figure 3.2 Chemical structure of calcein, the fluorophore used as an indication of lipid 
membrane leakage[27]. 
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CHAPTER 4: MATERIALS AND METHODS 
4.1 Materials 
 Samples of 1, 2-dioleoyl-phosphocholine (DOPC), 1, 2-dipaltimoyl-phosphocholine 
(DPPC) were purchased from Avanti Polar Lipids (Alabaster, AL). NaCl, EDTA (anhydrous), 
cholesterol, calcein, Triton X-100, Sephadex G-50, Sephadex G-75 were purchased from Sigma-
Aldrich (St. Louis , Mo). Extrusion drain disks and poly carbon filters were purchased from 
Nuclepore, Whatman Inc. (Clifton, NJ).  
4.2 Lipid Vesicle Preparation  
 Large unilamellar vesicles consisting of different lipid compositions were prepared by a 
technique that allows the lipid and cholesterol components which are stored in chloroform to be 
transferred from chloroform to an aqueous buffer solution. This technique involves the formation 
of multilamellar vesicles (MLVs) which are then pressure extruded through polycarbon filter 
membranes to make SUVs.  
4.3 Rapid Solvent Exchange 
 Multilamellar vesicles (MLVs) were prepared by rapid solvent exchange (RSE) 
method[28], where chloroform from the stock solutions is replaced with aqueous calcein buffer 
(150mM NaCl, 10mM Tris, 1mM EDTA and 70mM calcein; pH = 7.4). Through this method the 
lipid mixtures are directly transferred from the organic to aqueous phase. Additionally, this 
method ensures samples containing high concentrations of cholesterol do not undergo cholesterol 
crystallization. In brief, stock solutions of specific amounts of lipids were placed in 25 ml flat 
bottomed shell vials (Fisher Scientific, Inc.). In RES, 3 ml of calcein buffer heat to 
approximately 57⁰C was added to the lipid samples and vortexed mixed while being exposed to a 
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vacuum for 45 s. The vacuum allows the chloroform to evaporate, and the lipids to be transferred 
to the aqueous calcein buffer where the MLVs are formed. 
4.4 Pressure Extrusion and Size Exclusion Chromatography 
  The MLVs prepared by RES are extruded 5 times through double stacked 0.2µm pore 
sized membranes, followed by 8 times extrusion through 0.1 µm pore sized poly carbon filters 
forming SUVs. The SUVs were then passed through a Sephadex G50-packed column to remove 
the unencapsulated calcein dye. The vesicles were eluted with room temperature aqueous buffer 
(150mM NaCl, 10mM Tris, 1mM EDTA, pH 7.4) and samples were collected.  
4.5 Preliminary Analysis 
4.5.1 Dynamic Light Scattering (DLS)  
 The diameter of the vesicles was measured using a Malvern ZS90 Zetasizer dynamic 
light scattering (DLS) machine. This apparatus consists of a 5mW, He Ne Laser that operates at 
633nm wavelength. Measure of the polydispersity index, size distribution along with the 
effective diameter of liposomes was obtained. Table 4.1 shows the average diameter of the 
vesicles prepared. The data was given in terms of an effective diameter using the Stokes-Einstein 
equation:  
Effective diameter = 𝑘𝐵 𝑇
3 𝜋η 𝐷 (3)  
where KB is the Boltzmann constant, T is the temperature (25⁰C), η is the solvent viscosity, and 
D is the diffusivity.  
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4.6 Sonication  
 Leakage of calcein from the liposomes was performed by probe sonication. The 
ultrasound source used was a commercial (Hielscher Ultrasound Technology UP200H model 
from Germany) 24 kHz unit with a 2mm (diameter) transducer. The microtip was inserted into a 
cuvette containing 2 ml of vesicle solution, and was sonicated in a cold water bath that was 
maintained at a temperature of 20 ± 1⁰C to reduce the thermal effects of ultrasound. The vesicle 
solutions were sonicated in intervals of 30 seconds with three minutes intervals during which 
fluorescence measurements were obtained. The total sonication time reached was twenty two 
minutes. The sonication parameters are as shown on Table 4.2.   
4.7 Leakage Measurements  
 Fluorescence spectroscopy involves the emission of light from single excited states. First, 
the molecule is excited to a higher energy level, a process referred to as absorption, and then the 
molecule returns back to its ground state energy level during a process known as vibrational 
relaxation. As the molecule returns to the ground state energy is released in the form of light. In 
this experiments, the emission light from the fluorophore, calcein is detected by a fluorescence 
spectrometer. After the application of ultrasound, samples were analyzed using a fluorescence 
spectrometer to determine the leakage of calcein from the liposomes. Fluorescence intensities 
were measured using a TECAN, Infinite 200 PRO steady-state fluorescence spectrometer. The 
excitation wavelength was 480 nm with an emission range from 490nm to 545nm. The emissions 
intensity used to determine the fraction of release from the lipid vesicles was 535 nm.   
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Table 4.1 Average vesicle diameters with standard deviation for liposomes in each lipid phase.  
Lipid Composition Average Diameter (nm) Stdev (nm) 
Pure DOPC 119.3 0.12 
Liquid-disordered (10% chol) 125.1 1.45 
Liquid-liquid phase (20% chol) 117.2 1.92 
Liquid-ordered phase (50% 
chol) 
150.0 1.10 
Pure DPPC (solid-ordered 
phase) 
130.5 0.17 
DPPC 99%/DSPE-PEG20001% 116.0 
DPPC 95%/DSPE-PEG20005% 115.5 
DPPC 92%/DSPE-PEG20008% 117.0 
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Table 4.2 Settings and parameters of the probe sonicator.  
Microtip  
Probe 
Tip 
Diameter 
(mm) 
Max Amp 
(um)  
Intensity  Acoustic 
Density 
(W/cm2) 
S2/Micro 
Tip2 
2mm 260 5W/cm2 600 
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CHAPTER 5: RESULTS 
5.1 Introduction 
 The aim of this work was to study how lipid composition and phase behavior influence 
release of encapsulated molecules from liposomes using LFUS. This is important because it 
could offer valuable insight in the design of triggered drug delivery methods. The experiments 
performed investigated how different lipid compositions and phase behaviors of model 
membrane systems affect the interaction of ultrasound with the membrane. Additionally, the 
effect of PEG on the membranes susceptibility to ultrasound was evaluated.  
5.2 Lipid Composition and Membrane Phase Behavior   
 The role of cholesterol in membrane formation has been studied in the field of membrane 
biology. In the experiments described in this study, a ternary mixture of DOPC, DPPC, and 
cholesterol was used as a model because it has been extensively studied and their phase diagram 
is known [29]. Figure 5.1 shows the DOPC/DPPC/Cholesterol phase diagram, and the black dots 
indicate the membrane phases from which lipid vesicles prepared and analyzed in this study fall.  
 Briefly, liposome samples in pure DOPC, liquid-disordered (ld , 80%DOPC, 10% 
DPPC,10% cholesterol), liquid-liquid two phase region (40% DOPC, 40% DPPC, 20% 
cholesterol, liquid-ordered (lo, 20% DOPC, 30%DPPC, 50% cholesterol), and pure DPPC or 
solid-ordered (so) were prepared as described in chapter 4. Each sample was then sonicated with 
24 kHz probe sonicator in intervals of thirty seconds with three minutes off time until a total 
sonication time of twenty two minutes was reached. During sonication the liposome samples 
were immersed in water bath to maintain the temperature at 20 ± 1⁰C.  The samples were then 
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excited at 480nm and the emission scans were measured from 490 nm to 545nm. The sample sets 
used in this study are summarized in Table 5.1 and 5.2.  
 Figure 5.2 compares the emission spectra from a sample of pure DOPC liposomes that 
was sonicated at 24 kHz to the control sample not exposed to ultrasound. This figure is a clear 
indication that ultrasound does cause permeation of the liposome membrane.  It is also evident 
that the control sample containing the corresponding liposome mixture did not show any 
evidence of leakage. Figure 5.3 is the intensity profile of pure DOPC liposome samples subjected 
to ultrasound at a 24 kHz frequency.  According to the graph, there is an increase in fluorescence 
intensity as the length of sonication time increases. This graph is a good representation of the 
fact that increased exposure of liposomes to ultrasound results in increased release of dye.  
 Figure 5.4 shows the quantity of calcein released by sonication in comparison to the 
amount of calcein released after the liposomes are exposed to Triton X-100. This graph shows 
that there is complete rapture of the lipid membranes once they are exposed to Triton X-100 
which causes complete leakage of the encapsulated calcein. In comparison to the amount of 
calcein released after Triton X-100 exposure, the amount calcein released after ultrasound is very 
small. Unfortunately, there was not enough time to study why this could be the case. However, 
the trends shown by the figures 5.2 and 5.3 are a good indication that ultrasound is effective in 
causing membrane permeability. Similar graphs to Figure 5.2, 5.3 and 5.4 were obtained for each 
set of liposome compositions prepared.  
 Figure 5.5 shows a comparison of the release profile of all the liposomes prepared; pure 
DOPC, ld, liquid-liquid two phase region, lo and So regions. It is evident from this graph that the 
two liquid disordered phase samples consisting of pure DOPC and 10 % cholesterol show the 
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highest release. It is also evident that solid phase liposomes show less release as compared to 
both liquid-disordered phase liposomes and the liquid-liquid phase sample which has 20% 
cholesterol. Finally, it is clear that increasing cholesterol amounts reduces leakage as the graph 
shows the least release from liquid-ordered phase liposomes that have 50% cholesterol. Figure 
5.6 is a depiction of the release profile with the addition of error bars.  
5.3 Effect of PEG on solid-ordered Lipid Vesicles 
 The work of Lin and Thomas[7] demonstrated that the addition of covalently-linked 
poly(ethylene glycol) moiety (PEGylated lipids) into the membrane enhanced leakage and 
uptake. However, it has not been determined if the enhancement is a result of membrane 
destabilization, stabilization of pores or both. Work by Mona et al. [6] also showed that addition 
of PEG to small unilamellar vesicles enhanced ultrasound-induced leakage at specific molar 
concentrations of PEG. In this particular study, the influence of PEG was studied on solid-
ordered liposomes that consisted of DPPC lipid only. SUVs composed of 0 mol% PEG, 1 mol% 
PEG, 5 mol% PEG and 8 mol% PEG as shown on Table 5.3 were prepared and subjected to 
ultrasound for an ON time of thirty seconds and OFF time of three minutes for a total twenty two 
minutes.  
 Figure 5.7 shows the fluorescence intensity profile of lipid vesicles composed of DPPC 
99 mol% and 1 mol% PEG sonicated over time. The graph shows fluoresence intensity increase 
as sonication time increases. Figure 5.8 shows the release profile of all four PEGylated lipid 
compositions and it can be seen that both 1 mol% PEG and 5 mol% PEG showed enhanced 
ultrasound-induced leakage. However, it can be noted that 8 mol% PEG showed less leakage 
than the sample with 5 mol% PEG. Though the effect of PEG on the membrane is not fully 
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understood, it can be concluded that it does have an effect on the lipid vesicle membrane since it 
has been shown to make the membrane more responsive to ultrasound.  
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Table 5.1 Samples of pure DOPC and pure DPPC  
Lipid  Mol % Molarity (M) Volume (ul) 
DOPC 100% 1.55 183.3 
DPPC  100% 1.21 133.1 
 
Table 5.2 Ternary mixtures of DOPC/DPPC/cholesterol samples 
Liquid-disordered liposomes 
Lipid  Mol % Molarity 
(mM) 
Volume (ul) 
DOPC 80% 1.33 157.2 
DPPC 10% 0.16 18.35 
Cholesterol 10% 0.133 7.73 
 
Liposomes in 2 phase region 
Lipid  Mol % Molarity 
(mM) 
Volume (ul) 
DOPC 40% 0.67 78.6 
DPPC 40% 0.67 73.3 
Cholesterol 20% 0.26 15.0 
 
Liquid-ordered Liposomes 
Lipid  Mol % Molarity 
(mM) 
Volume (ul) 
DOPC 20% 0.33 39.3 
DPPC 30% 0.50 55.1 
Cholesterol 50% 0.66 38.7 
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Table 5.3 PEGylated Liposome Mixtures  
99% DPPC 1% DSPE-PEG2000 
Lipid  Mol % Molarity (mM) Volume (µl) 
DPPC 99% 1.21 133.1 
PEG 1% 0.0012 4.1 
 
95% DPPC 5% DSPE-PEG2000 
Lipid  Mol % Molarity (mM) Volume (µl) 
DPPC 95% 1.16 127 
PEG 5% 0.061 20.5 
 
92% DPPC 8% DSPE-PEG2000 
Lipid  Mol % Molarity (mM) Volume (µl) 
DPPC 92% 1.12 123.7 
PEG 8% 0.06 21.23 
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Figure 5.1 DOPC/DPPC/Cholesterol ternary system used in this study. Black dots (A-E) 
indicated the specific regions analyzed in this study [8]. 
 
 
 
 
 
 
 
 
 
27 
 
 
Figure 5.2 Pure DOPC lipid vesicles sonicated at 24 kHz compared to control sample which was 
not sonicated. The maximum intensity was seen at 534 nm.  
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Figure 5.3 Intensity Profile of calcein-leakage from pure DOPC liposomes. The SUVs were 
subjected to 24 kHz ultrasound. The figure shows that release of calcein increased as sonication 
time was increased.  
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Figure 5.4 Intensity profile of calcein leakage from pure DOPC SUVs. This graph shows 
maximum intensity after complete membrane rupture upon exposure to Triton X-100 in 
comparison to the intensity from ultrasound exposure.   
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Figure 5.5 Release profiles of DOPC/DPPC/Cholesterol SUVs. Highest release is shown by 
liquid-disordered liposomes with 0 %, 10%, 20% cholesterol. While lowest release is observed 
form the liquid-ordered liposomes with 50% cholesterol.  
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Figure 5.6 Release profiles of DOPC/DPPC/Cholesterol SUVs with error bars. Highest release is 
shown by liquid-disordered liposomes with 0% , 10%, 20% cholesterol. While lowest release is 
observed form the liquid-ordered liposomes with 50% cholesterol.  
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Figure 5.7 Intensity profile of calcein leakage from DPPC/DSPE-PEG2000 SUVs: The graph 
shows increase in leakage as sonication time increases.  
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Figure 5.8 Release profile of DPPC/DSPE-PEG2000 SUVs exposed to ultrasound at 24 kHz for 
30s bursts. Highest calcein leakage is displayed by vesicles with 5 mol% DSPE-PEG2000.  
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CHAPTER 6: DISCUSSION 
6.1 Effect of Lipid Phase Behavior  
 Targeted drug delivery through application of ultrasound to drug encapsulating lipid 
vesicles is important mainly because it allows for the controlled release of the drug at its 
intended location, and in a non invasive manner. This allows for the delivery of less amount of 
drugs, and for the prevention of potential toxic side effects [6, 30]. The work of Lin and Thomas 
[7]; Pong et al.[6]; Schroeder et al.[3] investigated the ability to control the release of drugs or 
molecules from liposomes using LFUS. These groups showed that LFUS facilitated drug release 
without affecting the drug's chemical integrity or biological potency.  
 The ternary system of DOPC/DPPC/Cholesterol was selected for this study because it 
allows for the study of how lipid compositions influence the membranes response to ultrasound. 
The influence of this particular model's phase behavior on ultrasound-induced leakage has been 
studied extensively by Small et al. [8] and found that increasing cholesterol amounts decreases 
leakage by ultrasound. The results displayed in Figure 5.5 and 5.6 are in agreement with their 
work in that liquid-ordered samples displayed less leakage compared to liquid-disordered 
samples upon exposure to ultrasound. 
 It can be concluded from the results in Figure 5.2 that without ultrasound, there is no 
transport of a water soluble molecule like calcein across a hydrophobic bilayer membrane. 
Additionally, it is evident that increasing cholesterol, causing a phase shift towards liquid-
ordered state, makes the membrane show more resistance to ultrasound and therefore reduces 
membrane leakage. In general, liposomes in the liquid-disordered phase are more permeable than 
liposomes in the solid ordered or liquid-ordered phases[1]. Liposomes that are transitioning 
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phases are even more permeable than liposomes in the liquid-disordered phase due to the large 
defects in the bilayer packing which is related to coexistence of solid-ordered and liquid-
disordered regions within the bilayer [31, 32]. Bilayers in the liquid-ordered phase, due to their 
free volume, are less sensitive to temperature changes and therefore less permeable, more stable, 
more rigid and have a lower degree of hydration  at the polar heads of the phospholipids in 
comparison to the liquid disordered phase [21].  
6.2 Effect of PEG Concentration  
 As mentioned in earlier, studies by Lin and Thomas [7] have indicated that PEGylated 
liposomes are more responsive to ultrasound. However, their studies also show that for DPPE-
PEG2000 concentrations greater than 8 mol%, the lipid membrane becomes saturated with PEG-
lipids and does not enhance leakage any further than 5 mol% compositions of PEG. In this study, 
the influence of DSPE-PEG2000 on solid-ordered lipids was tested and found to show almost 
similar results. Concentrations of 1 mol% and 5 mol% of PEG displayed increased leakage of 
calcein from solid-ordered vesicles as compared to vesicles consisting of pure DPPC. The 
sample composition with 8 mol% PEG showed less leakage compared to the 5 mol% sample. In 
spite of the fact that there was not enough time to collect more data to make a more conclusive 
analysis of the current results, it is evident that the concentration of polymer is important in 
studying its influence on ultrasound-induced leakage.  
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CHAPTER 7: CONCLUSION AND FURTHER STUDIES 
 In conclusion, simple model systems such as the one used in this study prove to be a 
useful tool as it can mimic the behavior of biological membranes in a controllable manner by 
adjusting lipid compositions. The goal of this research was to get a better understanding of the 
interaction of ultrasound and phospholipid membranes. This is important because liposomes are 
already used for drug delivery and ultrasound could help make the drug delivery process more 
effective by ensuring that specified drug concentrations reach their target site.   
 In a nutshell, the results analyzed in this study indicate that cholesterol influences phase 
behavior and plays a role on a membrane's susceptibility to ultrasound. That much said, more 
experiments depicting more regions in the DOPC/DPPC/Cholesterol ternary system would 
provide more information on how individual lipid phases interact with ultrasound. For instance, 
it would be interesting to study how lipid samples displaying different coexisting membrane 
phases would influence ultrasound-induced membrane leakage.  
The results from Figures 5.7 and 5.8 indicated that increasing poly (ethylene glycol) 
concentration to 5 mol% enhances ultrasound. Although additional experiments are necessary to 
confirm these results, the trends are in agreement with previous studies by Lin and Thomas [7] 
and Pong et al. [6]. In this study, the effect of PEG was only evaluated on solid-ordered phase 
samples only. Future, experiments could seek to determine if similar conclusions could be 
reached if PEG was added to liquid-ordered phase samples since they show the lowest release 
upon ultrasound exposure. This would add more insight on optimal PEG concentrations that 
would enhance ultrasound-induced leakage.  
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